US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist
  • 1.1371
  • -0.0129-1.12%
Close Nov 22 16:00 ET
  • 1.1371
  • 0.00000.00%
Post 20:01 ET
2.32MMarket Cap-85P/E (TTM)

Dermata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
78.02%3.23M
66.46%2.88M
40.65%3.2M
-16.88%8.04M
29.69%2.22M
-25.92%1.81M
-36.55%1.73M
-18.25%2.28M
23.13%9.67M
-32.95%1.71M
Selling and administrative expenses
-9.32%824.29K
-2.11%874.64K
47.72%1.6M
-1.28%3.97M
31.89%1.08M
1.82%909K
-20.08%893.48K
-8.84%1.09M
-8.51%4.02M
-42.94%822.33K
-General and administrative expense
-9.32%824.29K
-2.11%874.64K
47.72%1.6M
-1.28%3.97M
31.89%1.08M
1.82%909K
-20.08%893.48K
-8.84%1.09M
-8.51%4.02M
-42.94%822.33K
Research and development costs
165.94%2.4M
139.48%2.01M
34.22%1.6M
-27.98%4.07M
27.65%1.14M
-41.87%902.98K
-47.97%838.93K
-25.27%1.19M
63.36%5.65M
-20.01%889.36K
Operating profit
-78.02%-3.23M
-66.46%-2.88M
-40.65%-3.2M
16.88%-8.04M
-29.69%-2.22M
25.92%-1.81M
36.55%-1.73M
18.25%-2.28M
-23.13%-9.67M
32.95%-1.71M
Net non-operating interest income expense
-43.41%52.5K
75.96%54.64K
84.60%69.3K
288.87%247.22K
104.00%85.86K
331.76%92.77K
31.05K
37.54K
239.37%63.57K
42.09K
Non-operating interest income
-43.41%52.5K
75.96%54.64K
84.60%69.3K
288.87%247.22K
104.00%85.86K
331.76%92.77K
--31.05K
--37.54K
--63.57K
--42.09K
Other net income (expense)
Income before tax
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
Income tax
Net income
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
Net income continuous Operations
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
Minority interest income
Net income attributable to the parent company
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
8.16%-9.61M
34.60%-1.67M
Basic earnings per share
74.78%-2.04
55.67%-4.18
79.30%-7.05
80.82%-40.05
72.30%-8.1432
82.93%-8.09
83.88%-9.43
57.57%-34.05
64.20%-208.8
60.04%-29.4
Diluted earnings per share
74.78%-2.04
55.67%-4.18
79.30%-7.05
80.82%-40.05
72.30%-8.1432
82.93%-8.09
83.88%-9.43
57.57%-34.05
64.20%-208.8
60.04%-29.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 78.02%3.23M66.46%2.88M40.65%3.2M-16.88%8.04M29.69%2.22M-25.92%1.81M-36.55%1.73M-18.25%2.28M23.13%9.67M-32.95%1.71M
Selling and administrative expenses -9.32%824.29K-2.11%874.64K47.72%1.6M-1.28%3.97M31.89%1.08M1.82%909K-20.08%893.48K-8.84%1.09M-8.51%4.02M-42.94%822.33K
-General and administrative expense -9.32%824.29K-2.11%874.64K47.72%1.6M-1.28%3.97M31.89%1.08M1.82%909K-20.08%893.48K-8.84%1.09M-8.51%4.02M-42.94%822.33K
Research and development costs 165.94%2.4M139.48%2.01M34.22%1.6M-27.98%4.07M27.65%1.14M-41.87%902.98K-47.97%838.93K-25.27%1.19M63.36%5.65M-20.01%889.36K
Operating profit -78.02%-3.23M-66.46%-2.88M-40.65%-3.2M16.88%-8.04M-29.69%-2.22M25.92%-1.81M36.55%-1.73M18.25%-2.28M-23.13%-9.67M32.95%-1.71M
Net non-operating interest income expense -43.41%52.5K75.96%54.64K84.60%69.3K288.87%247.22K104.00%85.86K331.76%92.77K31.05K37.54K239.37%63.57K42.09K
Non-operating interest income -43.41%52.5K75.96%54.64K84.60%69.3K288.87%247.22K104.00%85.86K331.76%92.77K--31.05K--37.54K--63.57K--42.09K
Other net income (expense)
Income before tax -84.57%-3.17M-66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M
Income tax
Net income -84.57%-3.17M-66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M
Net income continuous Operations -84.57%-3.17M-66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M
Minority interest income
Net income attributable to the parent company -84.57%-3.17M-66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -84.57%-3.17M-66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M8.16%-9.61M34.60%-1.67M
Basic earnings per share 74.78%-2.0455.67%-4.1879.30%-7.0580.82%-40.0572.30%-8.143282.93%-8.0983.88%-9.4357.57%-34.0564.20%-208.860.04%-29.4
Diluted earnings per share 74.78%-2.0455.67%-4.1879.30%-7.0580.82%-40.0572.30%-8.143282.93%-8.0983.88%-9.4357.57%-34.0564.20%-208.860.04%-29.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data